Sign In
Buy JNJ
$241.00
+1.92 (+0.80%)
At Close: Jun 24, 2026
Why Johnson & Johnson Stock Flopped Today
05:46pm, Wednesday, 18'th Oct 2023
Two analysts trimmed their price targets on the pharmaceutical giant. Those cuts came a day after the company's latest earnings release.
1 Warren Buffett Stock to Buy Hand Over Fist Right Now
09:30am, Wednesday, 18'th Oct 2023
Berkshire Hathaway CEO Warren Buffett has a nearly unmatched track record as a stock picker. Johnson & Johnson, a long-time Berkshire Hathaway holding, screens as a solid pick for defensive investors.
Is the "New" Johnson & Johnson Stock a Buy With Its Improved Profit Outlook?
05:51am, Wednesday, 18'th Oct 2023
The healthcare giant had plenty of positives in its Q3 update. However, there are several issues to be concerned about with J&J over the next few years.
J&J's Medical Device Sales Feel the Side Effects of Weight-Loss Drugs
11:05pm, Tuesday, 17'th Oct 2023
Riding high, Johnson & Johnson reported pharmaceutical sales worth $13.89 billion on Tuesday (Oct 17), a year-over-year growth exceeding 5%. The pharmaceuticals driving its growth are Darzalex, a bi
Dividend Income Update September 2023
08:30pm, Tuesday, 17'th Oct 2023
With the start of the final quarter of 2023, it's time to take a look back at my previous month of dividend income. Getting close to that $2,000 milestone in a month sure looks amazing. I know, those
3-Stock Lunch: JNJ, GS & DLTR
03:41pm, Tuesday, 17'th Oct 2023
Hightower Advisor's Michael Farr, joins ‘Power Lunch' to discuss three stocks: Johnson & Johnson, Goldman Sachs and Dollar Tree.
J&J (JNJ) Beats Q3 Earnings & Sales Estimates Post Spin-Off
02:17pm, Tuesday, 17'th Oct 2023
J&J (JNJ) beats estimates for third-quarter earnings and sales. It raises full-year sales and earnings guidance.
J&J Beats Profit Estimates on Pharmaceutical, Medtech Sales as COVID-19 Shot Revenue Slows
12:05pm, Tuesday, 17'th Oct 2023
Johnson & Johnson (JNJ) reported better-than-anticipated results and raised its guidance as pharmaceutical and medical equipment sales gained, even with demand for its COVID-19 vaccine waning.
Retail Sales Hotter at +0.7%; JNJ, BAC, GS All Beat in Q3
12:01pm, Tuesday, 17'th Oct 2023
Retail Sales infer a consumer willing to spend, and the outlook for Q3 GDP is likely up somewhat on this news.
Retail Sales Increased More Than Expected
12:01pm, Tuesday, 17'th Oct 2023
This morning we see new Retail Sales numbers for September, and they have come in hotter than expected: headline +0.7% month over month is 50 basis points (bps) higher than expected, though down 10 bp
Johnson & Johnson Is Falling, but This Tech Stock Is Really Getting Hit Hard
10:00am, Tuesday, 17'th Oct 2023
Earnings season is beginning in earnest. Johnson & Johnson boosted its profit outlook on solid performance in its medical device and pharmaceutical segments.
Johnson & Johnson (JNJ) Q3 Earnings and Revenues Surpass Estimates
09:01am, Tuesday, 17'th Oct 2023
Johnson & Johnson (JNJ) came out with quarterly earnings of $2.66 per share, beating the Zacks Consensus Estimate of $2.52 per share. This compares to earnings of $2.55 per share a year ago.
Johnson & Johnson CFO Joseph Wolk on Q3 results: Very well-positioned into 2024 and beyond
08:25am, Tuesday, 17'th Oct 2023
Johnson & Johnson CFO Joseph Wolk joins 'Squawk Box' to discuss the company's quarterly earnings results, which topped quarterly earnings and revenue estimates, and more.
Johnson & Johnson ups guidance as earnings top forecasts
06:47am, Tuesday, 17'th Oct 2023
Johnson & Johnson (NYSE:JNJ) raised guidance after a strong third quarter which saw earnings beat expectations and its product pipeline advance. The New Brunswick (NYSE:BC), New Jersey-based pharmaceu
J&J's stock rallies after profit and sales rise above expectations, full-year outlook increased
06:39am, Tuesday, 17'th Oct 2023
Shares of Johnson & Johnson JNJ, +0.43% rallied 0.8% in premarket trading Tuesday, after the drug maker and medical technology company reported third-quarter profit and sales that rose above expectati
